FIDELIS CAPITAL PARTNERS, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1962755
TAMPA, FL
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$769,448
-$195,579 QoQ
Shares Held
1,234
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#706
of 1,322 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIDELIS CAPITAL PARTNERS, LLC holds $2,073,611 across 3 Biotechnology names. REGN ranks #2 (37.1% of the industry book) .
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $769,448 | 1,234 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $965,027 | 1,249 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $960,978 | 1,245 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $696,652 | 1,239 | Shares | Sole | 2025-11-03 | |
| 2025-03-31 | $270,816 | 427 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $318,411 | 447 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $526,671 | 501 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $561,250 | 534 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $404,245 | 420 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $319,697 | 364 | Shares | Sole | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||